APA (7th ed.) Citation

Lei, Y., Zhao, X., Qiao, C., Hong, M., Qian, S., Li, J., . . . Zhu, Y. Real-world comparison of flumatinib and nilotinib as first-line therapy for patients with chronic phase chronic myeloid leukemia: A multicenter retrospective study. SAGE Publishing.

Chicago Style (17th ed.) Citation

Lei, Yutian, Xiaoli Zhao, Chun Qiao, Ming Hong, Sixuan Qian, Jianyong Li, Weiming Li, and Yu Zhu. Real-world Comparison of Flumatinib and Nilotinib as First-line Therapy for Patients with Chronic Phase Chronic Myeloid Leukemia: A Multicenter Retrospective Study. SAGE Publishing.

MLA (9th ed.) Citation

Lei, Yutian, et al. Real-world Comparison of Flumatinib and Nilotinib as First-line Therapy for Patients with Chronic Phase Chronic Myeloid Leukemia: A Multicenter Retrospective Study. SAGE Publishing.